3857 |
TAVR - Year in Review |
Raj Makkar |
Apr. 21. 16 |
3856 |
PCI - Year in Review |
Neal S. Kleiman |
Apr. 21. 16 |
3855 |
How Evolut R Has Impacted My Practice? |
Eberhard Grube |
Apr. 21. 16 |
3854 |
New Balloons: SC/NC Euphora: The Defining Moment. When Technology Matches Expertise. |
Byeong-Keuk Kim |
Apr. 21. 16 |
3853 |
Growing Evidence to Support Aggressive CTO Therapy |
James Aaron Grantham |
Apr. 21. 16 |
3852 |
Introducing Corewire Technology & Challenging Cases with Onyx |
Duncan Hung Kwong Ho |
Apr. 21. 16 |
3851 |
When to Use IVUS vs. OCT - Complementary vs. Competitive? |
Gary S. Mintz |
Apr. 21. 16 |
3850 |
Optimizing Antiplatelet Therapy: Balancing Ischemic & Bleeding Risks |
David Joel Cohen |
Apr. 21. 16 |
3849 |
FFR Is Underutilized - Beyond Just Intermediate Lesions! |
William F. Fearon |
Apr. 21. 16 |
3848 |
Growth and Importance of Transcatheter Left Atrial Appendage Closure in AF |
Maurice Buchbinder |
Apr. 21. 16 |